242 related articles for article (PubMed ID: 15029470)
1. Dose-specific effects of scopolamine on canine cognition: impairment of visuospatial memory, but not visuospatial discrimination.
Araujo JA; Chan AD; Winka LL; Seymour PA; Milgram NW
Psychopharmacology (Berl); 2004 Aug; 175(1):92-8. PubMed ID: 15029470
[TBL] [Abstract][Full Text] [Related]
2. The scopolamine-reversal paradigm in rats and monkeys: the importance of computer-assisted operant-conditioning memory tasks for screening drug candidates.
Buccafusco JJ; Terry AV; Webster SJ; Martin D; Hohnadel EJ; Bouchard KA; Warner SE
Psychopharmacology (Berl); 2008 Aug; 199(3):481-94. PubMed ID: 17657478
[TBL] [Abstract][Full Text] [Related]
3. Cholinesterase inhibitors improve both memory and complex learning in aged beagle dogs.
Araujo JA; Greig NH; Ingram DK; Sandin J; de Rivera C; Milgram NW
J Alzheimers Dis; 2011; 26(1):143-55. PubMed ID: 21593569
[TBL] [Abstract][Full Text] [Related]
4. Aged dogs demonstrate both increased sensitivity to scopolamine impairment and decreased muscarinic receptor density.
Araujo JA; Nobrega JN; Raymond R; Milgram NW
Pharmacol Biochem Behav; 2011 Apr; 98(2):203-9. PubMed ID: 21238475
[TBL] [Abstract][Full Text] [Related]
5. Castration in rats impairs performance during acquisition of a working memory task and exacerbates deficits in working memory produced by scopolamine and mecamylamine.
Daniel JM; Winsauer PJ; Moerschbaecher JM
Psychopharmacology (Berl); 2003 Nov; 170(3):294-300. PubMed ID: 12898124
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of muscarinic receptor blockade in prelimbic cortex on acquisition and memory formation of an odor-reward task.
Carballo-Márquez A; Vale-Martínez A; Guillazo-Blanch G; Torras-Garcia M; Boix-Trelis N; Martí-Nicolovius M
Learn Mem; 2007 Sep; 14(9):616-24. PubMed ID: 17848501
[TBL] [Abstract][Full Text] [Related]
7. Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats.
de Bruin NM; Prickaerts J; van Loevezijn A; Venhorst J; de Groote L; Houba P; Reneerkens O; Akkerman S; Kruse CG
Neurobiol Learn Mem; 2011 Sep; 96(2):392-402. PubMed ID: 21757018
[TBL] [Abstract][Full Text] [Related]
8. Strain-dependent effects on acquisition and reversal of visual and spatial tasks in a rat touchscreen battery of cognition.
Kumar G; Talpos J; Steckler T
Physiol Behav; 2015 May; 144():26-36. PubMed ID: 25744936
[TBL] [Abstract][Full Text] [Related]
9. Further evidence for the cholinergic hypothesis of aging and dementia from the canine model of aging.
Araujo JA; Studzinski CM; Milgram NW
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Mar; 29(3):411-22. PubMed ID: 15795050
[TBL] [Abstract][Full Text] [Related]
10. 2-Phenylethynyl-butyltellurium enhances learning and memory impaired by scopolamine in mice.
Souza AC; Bruning CA; Acker CI; Neto JS; Nogueira CW
Behav Pharmacol; 2013 Aug; 24(4):249-54. PubMed ID: 23751517
[TBL] [Abstract][Full Text] [Related]
11. Nociceptin/orphanin FQ and nocistatin on learning and memory impairment induced by scopolamine in mice.
Hiramatsu M; Inoue K
Br J Pharmacol; 1999 Jun; 127(3):655-60. PubMed ID: 10401555
[TBL] [Abstract][Full Text] [Related]
12. Free operant and discrete trial performance of mice in the nine-hole box apparatus: validation using amphetamine and scopolamine.
Bensadoun JC; Brooks SP; Dunnett SB
Psychopharmacology (Berl); 2004 Jul; 174(3):396-405. PubMed ID: 14985934
[TBL] [Abstract][Full Text] [Related]
13. Ameliorative effects of histamine on spatial memory deficits induced by scopolamine infusion into bilateral dorsal or ventral hippocampus as evaluated by the radial arm maze task.
Xu LS; Fan YY; He P; Zhang WP; Hu WW; Chen Z
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):816-21. PubMed ID: 19215234
[TBL] [Abstract][Full Text] [Related]
14. A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment.
Klinkenberg I; Blokland A
Psychopharmacology (Berl); 2011 Jun; 215(3):549-66. PubMed ID: 21336581
[TBL] [Abstract][Full Text] [Related]
15. Reversal of a cholinergic-induced deficit in a rodent model of recognition memory by the selective 5-HT6 receptor antagonist, Ro 04-6790.
Woolley ML; Marsden CA; Sleight AJ; Fone KC
Psychopharmacology (Berl); 2003 Dec; 170(4):358-67. PubMed ID: 13680084
[TBL] [Abstract][Full Text] [Related]
16. Assessment of a combination of physostigmine and scopolamine as pretreatment against the behavioural effects of organophosphates in the common marmoset (Callithrix jacchus).
Muggleton NG; Bowditch AP; Crofts HS; Scott EA; Pearce PC
Psychopharmacology (Berl); 2003 Mar; 166(3):212-20. PubMed ID: 12589520
[TBL] [Abstract][Full Text] [Related]
17. Specific impairments in visuospatial working and short-term memory following low-dose scopolamine challenge in healthy older adults.
Thomas E; Snyder PJ; Pietrzak RH; Jackson CE; Bednar M; Maruff P
Neuropsychologia; 2008 Aug; 46(10):2476-84. PubMed ID: 18514746
[TBL] [Abstract][Full Text] [Related]
18. The role of the central cholinergic projections in cognition: implications of the effects of scopolamine on discrimination learning by monkeys.
Harder JA; Baker HF; Ridley RM
Brain Res Bull; 1998; 45(3):319-26. PubMed ID: 9510426
[TBL] [Abstract][Full Text] [Related]
19. Rats with scopolamine- or MK-801-induced spatial discrimination deficits in the cone field task: animal models for impaired spatial orientation performance.
Bouger PC; van der Staay FJ
Eur Neuropsychopharmacol; 2005 May; 15(3):331-46. PubMed ID: 15820423
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
